Organogenesis Holdings Inc.
ORGO • NASDAQ • Stock Fundamentals
Organogenesis Holdings Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Gary S. Gillheeney, with a market cap of $306.2M.
Market Cap$306.2M
Employees862.0
CEOGary S. Gillheeney
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Organogenesis Holdings Inc. FAQ
Common questions about Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) has a market capitalization of $306.2M and trades on NASDAQ.
Organogenesis Holdings Inc. has approximately 862 employees.